Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

358 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
A randomized, double-blind, placebo-controlled clinical trial of the effectiveness of the novel serotonin type 3 receptor antagonist ramosetron in both male and female Japanese patients with diarrhea-predominant irritable bowel syndrome.
Matsueda K, Harasawa S, Hongo M, Hiwatashi N, Sasaki D. Matsueda K, et al. Among authors: sasaki d. Scand J Gastroenterol. 2008;43(10):1202-11. doi: 10.1080/00365520802240255. Scand J Gastroenterol. 2008. PMID: 18618371 Clinical Trial.
[Irritable bowel syndrome in the elderly].
Sasaki D, Fukushi T, Sato K, Takimoto M, Nakahata H, Munakata A. Sasaki D, et al. Nihon Rinsho. 2006 Aug;64(8):1516-20. Nihon Rinsho. 2006. PMID: 16898624 Review. Japanese.
High prevalence of irritable bowel syndrome in medical outpatients in Japan.
Shinozaki M, Fukudo S, Hongo M, Shimosegawa T, Sasaki D, Matsueda K, Harasawa S, Miura S, Mine T, Kaneko H, Arakawa T, Haruma K, Torii A, Azuma T, Miwa H, Fukunaga M, Handa M, Kitamori S, Miwa T; IBS Club. Shinozaki M, et al. Among authors: sasaki d. J Clin Gastroenterol. 2008 Oct;42(9):1010-6. doi: 10.1097/MCG.0b013e318150d006. J Clin Gastroenterol. 2008. PMID: 18607295
358 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page